Learn how and where to inject Zepbound and where to get additional help. Plus, get tips for injecting the drug at home and ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

TOKYO -- U.S. drugmaker Eli Lilly has released its Zepbound obesity medication in Japan, targeting the millions said to suffer from the "hidden" scourge of buildups of visceral fat.

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

President Trump was talking to reporters Friday after Dr. Oz's swearing-in ceremony when the news conference abruptly ended.

The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, stab-free way to treat diabetes and obesity.

While not officially approved, Eli Lilly says it could be an alternative to injectable drugs like ozempic as a once-a-day ...

Who could take the new weight-loss pill? In a nine-month trial on patients with type 2 diabetes, those on the highe ...

U.S. drugmaker Eli Lilly has released its Zepbound obesity medication in Japan, targeting the millions said to suffer from the "hidden" scourge of buildups of visceral fat. "We believe there are 16 to ...

Zoom out: The positive results sent Lilly's stock soaring 16% Thursday to $852. Bank of America's Anderson projected 2030 ...